Pages
DCHS SIM-swap project – important information for laptop users
DCHS SIM-swap project - 5 weeks to swap out over 2,500 laptops. Mostly laptops that are used by mobile workers (ie clinicians that go in to patients homes).
Derbyshire health and care system under increasing pressure and declares Critical Incident
Staff Briefing - Derbyshire health and care system under increasing pressure and declares Critical Incident
Parking at St Oswald’s and Long Eaton - April 2025
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/parking-st-oswalds-and-long-eaton-update
PAT Testing for remote workers in DCHS
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/pat-testing-remote-workers-dchs
Files
Unopposed-declaration-Staff-OtherRegisteredProfessionals.pdf
Unopposed-declaration-Staff-OtherRegisteredProfessionals
NPWT Initiated by DCHS Tissue Viability Team (P11)
NPWT Initiated by DCHS Tissue Viability Team (P11)
0066 - Record Sheet for Daily Operation of Drinking Water Fountains (P69)
0066 - Daily Record Sheet for Daily Operation of Drinking Water Fountains
North Derbyshire OPAT (Outpatient Parenteral Antimicrobial Therapy) Pathway for Primary Care (Step-Up Pathway/Admission Avoidance) (G198)
OPAT services provide intravenous (IV) antibiotics to patients outside of the acute hospital inpatient setting. Patients who are otherwise medically fit, and who would otherwise require a hospital bed, can avoid admission to hospital, or be discharged sooner by receiving treatment either as an outpatient or within their own homes. In North Derbyshire, this is achieved by Chesterfield Royal Hospital Foundation Trust (CRHFT) working in partnership with Derbyshire Community Health Services (DCHS) Rapid Response Team (RRT).
0501 - In-patient Care Plans
0501 - Inpatient Care Plan
Moisture Associated Skin Damage Barrier Film Pathway (G197)
Moisture Associated Skin Damage Barrier Film Pathway including MEDI DERMA-S Instructions for Use Guide
Intravenous Therapy and Vascular Access Device (VAD) Policy - Adults (P47)
The use of intravenous medicines has many healthcare benefits for patients. Intravenous medicines are increasingly commonplace within the community setting and the need for an intravenous medicine is often a reason for patient’s being admitted to secondary care. Following the implementation of national and local policy, there is a new direction for community care providers such as DCHS to develop services that can be provided within the community hospital or community setting to accommodate patient’s being able to receive more complex care. The aims of this policy are: To prevent unnecessary acute hospital admission and to facilitate early discharge from the acute hospital setting by enabling patients to receive IV medicines safely within their own home or a community health care setting. To ensure an IV medicine is the most appropriate treatment for the patient and that it is administered via the most appropriate Vascular Access Device, the most appropriate vascular access site is chosen and the IV medicine is administered at the right time. To reduce the risk of complications by ensuring registered practitioners’ practice safely and consistently in relation to the administration of IV medicines, Vascular Access Device Insertion and the care and maintenance of Vascular Access Devices (VADs), through the implementation of evidence-based practice and by providing staff with the necessary guidance on clinical practice and training. To preserve and promote patient vessel health in the short and long term by ensuring any Vascular Access Device inserted is the most appropriate device for the treatment being administered and that it is placed by the most appropriately qualified practitioner.
L145 - Important advice for casts on lower limbs
Important advice for casts on lower limbs, patient information leaflet.
CoG - 11 March 2020 - updated.pdf
CoG Meeting Pack March 2020